Objective:To analyze the research progress and hotspots of clinical pathway informatization at home and abroad, and provide references and guidance for the construction of clinical pathway informatization in China.Methods:The relevant literature on clinical pathway informatization research were retrieved from China National Knowledge Infrastructure and Web of Science databases, which were published from January 1, 2000 to July 20, 2023. Bibliometric and thematic analysis methods were used to analyze the commonalities and differences in annual publication volume, high-frequency author collaboration networks, high-frequency keywords, and research hotspots of domestic and foreign literature.Results:This study included a total of 257 domestic literature and 174 foreign literature. The number of domestic publications had gradually increased since 2005, with the highest number in 2012 and a significant downward trend after 2015; The overall number of foreign publications was on the rise. Domestic high-frequency authors mostly came from medical institutions, while foreign high-frequency authors were mainly concentrated in universities and research institutes, and both had formed author collaboration networks. However, the research continuity of foreign authors were better than that of domestic authors. There were commonalities in the electronicization and semantics of clinical pathways, process design and management, disease management, and clinical decision support in relevant research hotspots at home and abroad, but there were significant differences in system integration, process design, pathway analysis, and disease management. Foreign related researches had the advantages of leading technology.Conclusions:There were certain similarities and differences in the research topics of clinical pathway informatization at home and abroad, and relevant studies abroad had shown certain frontiers in the application of new technologies. In the future, China should learn from international advanced experience, utilize emerging technologies such as machine learning and big language models, strengthen patient-centered, promote the precise and intelligent development of clinical pathway management, and improve the quality of medical services.

Objective:To analyze the research progress and hotspots of clinical pathway informatization at home and abroad, and provide references and guidance for the construction of clinical pathway informatization in China.Methods:The relevant literature on clinical pathway informatization research were retrieved from China National Knowledge Infrastructure and Web of Science databases, which were published from January 1, 2000 to July 20, 2023. Bibliometric and thematic analysis methods were used to analyze the commonalities and differences in annual publication volume, high-frequency author collaboration networks, high-frequency keywords, and research hotspots of domestic and foreign literature.Results:This study included a total of 257 domestic literature and 174 foreign literature. The number of domestic publications had gradually increased since 2005, with the highest number in 2012 and a significant downward trend after 2015; The overall number of foreign publications was on the rise. Domestic high-frequency authors mostly came from medical institutions, while foreign high-frequency authors were mainly concentrated in universities and research institutes, and both had formed author collaboration networks. However, the research continuity of foreign authors were better than that of domestic authors. There were commonalities in the electronicization and semantics of clinical pathways, process design and management, disease management, and clinical decision support in relevant research hotspots at home and abroad, but there were significant differences in system integration, process design, pathway analysis, and disease management. Foreign related researches had the advantages of leading technology.Conclusions:There were certain similarities and differences in the research topics of clinical pathway informatization at home and abroad, and relevant studies abroad had shown certain frontiers in the application of new technologies. In the future, China should learn from international advanced experience, utilize emerging technologies such as machine learning and big language models, strengthen patient-centered, promote the precise and intelligent development of clinical pathway management, and improve the quality of medical services.

Purpose/Significance By summarizing the construction experience of the immunology database and analysis portal(ImmPort),the study aims to provide insights and references for the development of a large-scale immunology database in China.Method/Process It comprehensively analyzes the architecture of ImmPort and the functionalities of its various modules,and delineates the data flow for data collection,organization,sharing,and analysis within the database.Finally,it summarizes the practical achieve-ments of the ImmPort platform.Result/Conclusion In the process of constructing the immunology database,our country should prioritize the standardization of data organization and modeling.Standardized terminology should be actively adopted to provide semantic support,and data sharing should be carried out in the management of classification and grading,while developing a supporting tool system to en-sure the safe and effective sharing and utilization of immunology data.

Purpose/Significance To meet the urgent needs of mass data analysis and application in the biomedical field and solve the problems such as the lack of standardized management of data analysis and utilization tools.Method/Process The paper comprehen-sively analyzes and summarizes the construction ideas,methods and technical realization of the tool standardization collection,manage-ment and shared utilization of ELIXIR's biomedical data tool service platform system.Some suggestions are put forward from the aspects of ecosystem construction,management norms,operation environment management,benchmark testing and verification,technology renewal strategy and community-driven innovation.Result/Conclusion The useful experience in the construction of ELIXIR's data tool service platform system is learned to provide comprehensive references for the standardized management of biomedical data analysis and utilization tools and service platform construction in China.

The specific aspects of big data management practice for the Million Veteran Program (MVP) in USA were summarized by investigating it with network survey method and literature survey method, including large scale collection of data, structure of data management organizations, platform for data integration, privacy and security of data.The enlightenments of big data management practice for the MVP in USA on big data management of precision medicine in China were analyzed from 5 aspects.

The paper focuses on precision medical initiatives of China,the United States and Britain.It outlines their main aims and tasks,and compares the implementation,data management and sharing of initiatives.Some enlightenment is summarized to provide references for China to carry out national key research,and development program of precision medical research.

Based on the social background of increasingly serious aging of the population and the growth of chronic diseases,the paper introduces the mode of Connected Health (cHealth),analyzes the differences between cHealth and Mobile Health (mHealth) as well as the advantages of cHealth,introduces the application of cHealth in contemporary society,and discusses the challenges of cHealth,including the optimization of sensing strategy,creation of data integration,analysis on the new mode,optimization of feedback strategy and development of new health insurance modes.

The relevance analysis methods for the association between environmental factors (air pollutants, fine particles, climate conditions, toxic materials) and diseases (lung cancer and asthma, etc) were studied by mining the open access scientific data in American environmental health field, which realized their practical application and can thus provide reference for studying the association between environments and diseases in our country.

Wearable technology, widely applied in health and medical field, has become an important part of in-telligent healthcare and medicare. However, the data security and privacy protection of wearable health and medi-cal devices are greatly concerned and need to be solved. The characteristics of data security and privacy protection of wearable health and medical devices were thus analyzed and compared with those of traditional health and medi-cal devices. The related studies and laws on domestic and foreign wearable health and medical devices were summa-rized, and the advances, experiences and problems in domestic and foreign wearable health and medical devices were analyzed and compared in order to provide reference for establishing the mechanisms underlying their data se-curity and privacy protection.

The index system of comparative advantages was constructed for the pharmaceutical manufacturing in-dustry in different provinces , municipalities directly under the Central Government , and autonomous regions ac-cording to the integrated comparative advantage theory .The integrated comparative advantages in different provinces , municipalities directly under the Central Government , and autonomous regions were scored by principal component analysis and qualitatively analyzed by clustering analysis to reveal their spatial distribution , thus providing the deci-sion-making support for the policy makers, manufacturers, investors and staff of pharmaceutical manufacturing in-dustry.